RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
MERLANO MC
Collezione AO Cuneo
Items : 51
Baseline Cytokine Profile Identifies a Favorable Outcome in a Subgroup of Colorectal Cancer Patients Treated with Regorafenib. in Vaccines / Vaccines (Basel). 2023 Feb 2;11(2):335. doi: 10.3390/vaccines11020335.
2023
AO Cuneo
Abbona A; Ricci V; Paccagnella M; Granetto C; Ruatta F; Cauchi C; Galizia D; Ghidini M; Denaro N; Merlano MC; Garrone O;
Why Oncologists Should Feel Directly Involved in Persuading Patients with Head and Neck Cancer to Quit Smoking. in Oncology / Oncology. 2023;101(4):252-256. doi: 10.1159/000528345. Epub 2022 Dec 20.
2023
AO Cuneo
Bossi P; Garrone O; Galizia D; Abbona A; Paccagnella M; Minei S; Merlano MC; Denaro N;
How Chemotherapy Affects the Tumor Immune Microenvironment: A Narrative Review. in Biomedicines / Biomedicines. 2022 Jul 28;10(8):1822. doi: 10.3390/biomedicines10081822.
2022
AO Cuneo
Garrone O; Ghidini M; Paccagnella M; Abbona A; Minei S; Denaro N; Galizia D; Ruatta F; Occelli M; Merlano MC;
Cytokine Profiling of End Stage Cancer Patients Treated with Immunotherapy. in Vaccines / Vaccines (Basel). 2021 Mar 8;9(3):235. doi: 10.3390/vaccines9030235.
2021
AO Cuneo
Basiricò M; Gammaitoni L; Galizia D; Crosetto N; Bertetto O; Merlotti A; Ruatta F; Denaro N; Fea E; Ricci V; Granetto C; Falletta A; Paccagnella M; Abbona A; Merlano MC; Sangiolo D; Aglietta M; Garrone O;
Unusual Fatal Outcome Following Administration of a Combination of anti-PD1 and anti-CTLA4 in Metastatic Renal Cell Carcinoma: Liver Toxicity Case Report and a Literature Review. in European journal of case reports in internal medicine / Eur J Case Rep Intern Med. 2021 Jun 17;8(7):002639. doi: 10.12890/2021_002639. eCollection 2021.
2021
AO Cuneo
Denaro N; Garrone O; Occelli M; Fea E; Granetto C; Merlano MC; Numico G;
Further Understanding of the Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: Implications for Prognosis. in Cancer management and research / Cancer Manag Res. 2021 May 17;13:3973-3980. doi: 10.2147/CMAR.S277907. eCollection 2021.
2021
AO Cuneo
Denaro N; Merlano MC; Lo Nigro C;
Effect of moderate physical exercise on the immune system modulation in patients with breast cancer during preoperative chemotherapy: The NEO-RUNNER study in Journal of Clinical Oncology
2021
AO Cuneo
Ruatta F; Denaro N; Merlano MC; Prina AV; Rubini D; Vanella P; Paccagnella M; Croce N; Falletta A; Abbona A; Garrone O; Vandone AM;
Cytokines performance during nivolumab treatment: A subgroup analysis of NIVACTOR study in Journal of Clinical Oncology
2021
AO Cuneo
De Zarlo L; Fiorino E; Gammaitoni L; Falletta A; Abbona A; Galizia D; Denaro N; Paccagnella M; Aglietta M; Merlano MC; Licitra LF; Sangiolo D; Bossi P;
Treating patients with cancer amidst the COVID-19 pandemic: experience of a regional hospital in the Piedmont region in northern Italy. in Tumori / Tumori. 2020 Oct;106(5):427-431. doi: 10.1177/0300891620942313. Epub 2020 Jul 23.
2020
AO Cuneo
Crosetto N; Colantonio I; Di Costanzo G; Fea E; Ricci V; Cauchi C; Occelli M; Vandone AM; Granetto C; Vanella P; Ruatta F; Denaro N; Garrone O; Merlano MC;
VEGF-Related Germinal Polymorphisms May Identify a Subgroup of Breast Cancer Patients with Favorable Outcome under Bevacizumab-Based Therapy-A Message from COMET, a French Unicancer Multicentric Study. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2020 Nov 23;13(11):414. doi: 10.3390/ph13110414.
2020
AO Cuneo
Gal J; Milano G; Brest P; Ebran N; Gilhodes J; Llorca L; Dubot C; Romieu G; Desmoulins I; Brain E; Goncalves A; Ferrero JM; Cottu PH; Debled M; Tredan O; Chamorey E; Merlano MC; Lemonnier J; Etienne-Grimaldi MC; Pierga JY;
Immune escape mechanisms in head and neck squamous cell carcinoma and implication for new immunotherapy approach. in Current opinion in oncology / Curr Opin Oncol. 2020 May;32(3):203-209. doi: 10.1097/CCO.0000000000000623.
2020
AO Cuneo
Merlano MC; Denaro N; Garrone O;
Circulating cytokines and outcome in metastatic colorectal cancer patients treated with regorafenib. in World journal of gastrointestinal oncology / World J Gastrointest Oncol. 2020 Mar 15;12(3):301-310. doi: 10.4251/wjgo.v12.i3.301.
2020
AO Cuneo
Ricci V; Granetto C; Falletta A; Paccagnella M; Abbona A; Fea E; Fabozzi T; Lo Nigro C; Merlano MC;
Coronavirus disease 19 (COVID-19) during chemoradiation for locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC). in Oral oncology / Oral Oncol. 2020 Aug;107:104801. doi: 10.1016/j.oraloncology.2020.104801. Epub 2020 May 14.
2020
AO Cuneo
Russi E; Merlano MC; Merlotti AM; Denaro N;
Coronavirus disease 19 (COVID-19) during chemoradiation for locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC). in Oral oncology / Oral Oncol. 2020 Aug;107:104801. doi: 10.1016/j.oraloncology.2020.104801. Epub 2020 May 14.
2020
AO Cuneo
Denaro N; Merlotti AM; Merlano MC; Russi E;
The Impact of Locoregional Treatment on Response to Nivolumab in Advanced Platinum Refractory Head and Neck Cancer: The Need Trial. in Vaccines / Vaccines (Basel). 2020 Apr 20;8(2):191. doi: 10.3390/vaccines8020191.
2020
AO Cuneo
Polimeni A; Vici P; Salati M; Ronzino G; Pizzuti L; Cortellini A; Cassano A; Di Dio C; Cirillo A; Mammone G; Roberto M; Cerbelli B; Sciattella P; Pomati G; Mezi S; Botticelli A; Merlano MC; Nuti M; Marchetti P;
Metastatic disease in head & neck oncology. in Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale / Acta Otorhinolaryngol Ital. 2020 Apr;40(SUPPL. 1):S1-S86. doi: 10.14639/0392-100X-suppl.1-40-2020.
2020
ASL Asti
ASL Vercelli
ASL Torino 3
AOU Città della Salute di Torino
AO Cuneo
AOU Alessandria
AOU Novara
Zannetti M; Valente G; Serra A; Scasso F; Prioglio L; Rugiu MG; Prina-Mello A; Pisani S; Masini L; Merlano MC; Piemonte M; Maroldi R; Mancuso M; Magnano M; Lanza GV; Landolfo V; Iasi GA; Krengli M; Genta I; Garzaro M; Galizia D; Fantozzi C; Denaro N; Costanzo A; Della Vecchia L; Conti B; Colombo A; Zigliani A; Cacciola S; et alii...
Phase III Randomized Study of Induction Chemotherapy Followed by Definitive Radiotherapy + Cetuximab Versus Chemoradiotherapy in Squamous Cell Carcinoma of Head and Neck: The INTERCEPTOR-GONO Study (NCT00999700). in Oncology / Oncology. 2020;98(11):763-770. doi: 10.1159/000507733. Epub 2020 Jul 6.
2020
AO Cuneo
Merlano MC; Denaro N; Vecchio S; Licitra L; Curcio P; Benasso M; Bagicalupo A; Numico G; Russi E; Corvo' R; Bruzzi P;
The impact of locoregional treatment on response to nivolumab in advanced platinum refractory head and neck cancer: The need trial in Journal of Clinical Oncology
2020
AO Cuneo
Marchetti P; Nuti M; Merlano MC; Roberto M; Cirillo A; Mammone G; Cassano A; Di Dio C; Cortellini A; Pizzuti L; Ronzino G; Salati M; Vici P; Sciattella P; Pomati G; Mezi S; Botticelli A;
Unexpected response with palliative conventional therapy in head and neck squamous cell carcinoma after anti-programmed death-1 progression. in Head & neck / Head Neck. 2019 Mar;41(3):E42-E47. doi: 10.1002/hed.25418. Epub 2019 Jan 5.
2019
AO Cuneo
Merlano MC; Denaro N;
NK-mediated antibody-dependent cell-mediated cytotoxicity in solid tumors: biological evidence and clinical perspectives. in Annals of translational medicine / Ann Transl Med. 2019 Mar;7(5):105. doi: 10.21037/atm.2019.01.42.
2019
AO Cuneo
Lo Nigro C; Macagno M; Sangiolo D; Bertolaccini L; Aglietta M; Merlano MC;
Melanoma: the new perspectives from clinical and translational research. in Anti-cancer drugs / Anticancer Drugs. 2019 Jul;30(6):543-553. doi: 10.1097/CAD.0000000000000798.
2019
AO Cuneo
Occelli M; Vandone AM; Cauchi C; Merlano MC;
Long noncoding RNAs as regulators of cancer immunity. in Molecular oncology / Mol Oncol. 2019 Jan;13(1):61-73. doi: 10.1002/1878-0261.12413. Epub 2018 Dec 13.
2019
AO Cuneo
Denaro N; Merlano MC; Lo Nigro C;
Knowing the tumour microenvironment to optimise immunotherapy. in Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale / Acta Otorhinolaryngol Ital. 2019 Feb;39(1):2-8. doi: 10.14639/0392-100X-2481.
2019
AO Cuneo
Merlano MC; Abbona A; Denaro N; Garrone O;
Selection of systemic therapy in patients with locally advanced and recurrent/metastatic head and neck cancer: RAND-based expert opinion by an Italian multidisciplinary panel. in Tumori / Tumori. 2019 Aug 28:300891619868289. doi: 10.1177/0300891619868289.
2019
AO Cuneo
Bonomo P; Benasso M; Buglione M; Ghi MG; Licitra L; Magrini SM; Merlano MC; Presutti L; Ronzino G; Ferrari D;
In response to Ham et al.: Antibiotics effect on outcome in head and neck cancer. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2019 Aug;117:119-120. doi: 10.1016/j.ejca.2019.05.021. Epub 2019 Jul 3.
2019
AO Cuneo
Denaro N; Merlano MC;
Lenvatinib Long-Term Responses in Refractory Thyroid Cancer: Our Mono-Institutional Real-Life Experience with the Multidisciplinary Approach and Review of Literature. in Oncology / Oncology. 2019;97(4):206-210. doi: 10.1159/000501691. Epub 2019 Aug 7.
2019
AO Cuneo
Merlano MC; Borretta G; Corrado L; Bramardi F; Cesario F; Latina A; Denaro N;
How I treat squamous ENT cancer. in ESMO open / ESMO Open. 2019 Jul 16;4(Suppl 2):e000542. doi: 10.1136/esmoopen-2019-000542. eCollection 2019.
2019
AO Cuneo
Merlano MC; Denaro N; Galizia D; Garrone O;
DUSP2 methylation is a candidate biomarker of outcome in head and neck cancer. in Annals of translational medicine / Ann Transl Med. 2018 Jul;6(13):271. doi: 10.21037/atm.2018.06.39.
2018
AO Cuneo
Lo Nigro C; Vivenza D; Denaro N; Lattanzio L; Fortunato M; Crook T; Merlano MC;
Immunotherapy in Head and Neck Squamous Cell Cancer. in Clinical and experimental otorhinolaryngology / Clin Exp Otorhinolaryngol. 2018 Dec;11(4):217-223. doi: 10.21053/ceo.2018.00150. Epub 2018 Jul 6.
2018
AO Cuneo
Merlano MC; Denaro N;
Impact of treatment expertise on the outcome of patients with head and neck cancer treated within 6 randomized trials. in Head & neck / Head Neck. 2018 Dec;40(12):2648-2656. doi: 10.1002/hed.25389. Epub 2018 Nov 17.
2018
AO Cuneo
Dani C; Infante G; Merlano MC; Fallai C; Sanguineti G; Bacigalupo A; Corvò R; Benasso M; Miceli R; Bossi P; Di Giannantonio V; Licitra L;
Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide. in Clinical and translational radiation oncology / Clin Transl Radiat Oncol. 2018 Aug 13;12:47-52. doi: 10.1016/j.ctro.2018.08.001. eCollection 2018 Au
2018
AO Ordine Mauriziano
AO Cuneo
Corvò R; Russi EG; Vecchio S; Curcio P; Fruttero C; Galizia D; Di Maio M; Denaro N; Fea E; Licitra L; Merlano MC; Merlotti AM;
Incidence of cetuximab-related infusion reaction in head and neck cancer patients: may we predict it? in ESMO open / ESMO Open. 2018 Jun 20;3(4):e000404. doi: 10.1136/esmoopen-2018-000404. eCollection 2018.
2018
AO Cuneo
Merlano MC; Garrone O;
Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2017 Oct 1;28(10):2526-2532. doi: 10.1093/annonc/mdx344.
2017
AO Cuneo
Ehrnrooth E; Machiels JH; Solca F; Gibson N; Cong XJ; Krämer N; Dupuis N; Merlano MC; Geoffrois L; Guigay J; Tahara M; Vermorken JB; Haddad RI; Mailliez A; Del Campo JM; Grau JJ; Clement PM; Gauler T; Fayette J; Burtness B; Cohen EEW; Licitra LF;
Eribulin in advanced breast cancer: safety, efficacy and new perspectives. in Future oncology (London, England) / Future Oncol. 2017 Dec;13(30):2759-2769. doi: 10.2217/fon-2017-0283. Epub 2017 Sep 13.
2017
AO Cuneo
Merlano MC; Lingua D; Vandone AM; Vanella P; Miraglio E; Garrone O;
Heterogeneity of colon cancer: from bench to bedside. in ESMO open / ESMO Open. 2017 Aug 22;2(3):e000218. doi: 10.1136/esmoopen-2017-000218. eCollection 2017.
2017
AO Cuneo
Garrone O; Ricci V; Fea E; Merlano MC; Granetto C;
Gemcitabine-Based Chemoradiation in the Treatment of Locally Advanced Head and Neck Cancer: Systematic Review of Literature and Meta-Analysis. in The oncologist / Oncologist. 2016 Jan;21(1):59-71. doi: 10.1634/theoncologist.2015-0246. Epub 2015 Dec 28.
2016
AO Cuneo
Vanderveken OM; Szturz P; Specenier P; Merlano MC; Benasso M; Van Gestel D; Wouters K; Van Laer C; Van den Weyngaert D; Peeters M; Vermorken J;
Follow-up in Head and Neck Cancer: Do More Does It Mean Do Better? A Systematic Review and Our Proposal Based on Our Experience. in Clinical and experimental otorhinolaryngology / Clin Exp Otorhinolaryngol. 2016 Dec;9(4):287-297. doi: 10.21053/ceo.2015.00976. Epub 2016 Jun 25.
2016
AO Cuneo
Denaro N; Merlano MC; Russi EG;
Eribulin in pretreated metastatic breast cancer patients: results of the TROTTER trial-a multicenter retrospective study of eribulin in real life. in SpringerPlus / Springerplus. 2016 Jan 21;5:59. doi: 10.1186/s40064-016-1700-0. eCollection 2016.
2016
ASL Torino 4
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Biella
ASL Vercelli
ASL Alessandria
AOU Novara
Merlano MC; Polimeni MA; Oletti MV; Lucio F; Airoldi M; De Conciliis E; La Verde N; Vandone AM; Donadio M; Giacobino A; Saggia C; Montemurro F; Garrone O;
How to enhance nonprofit clinical research in a General Hospital in Annals of Oncology
2016
AO Cuneo
Violante S; Merlano MC; Lattanzio L; Giurlanda F; Curcio P;
Tumor-infiltrating lymphocytes (TILs) density as prognostic determinant in stage II colorectal cancer in Annals of Oncology
2016
AO Cuneo
Ricci V; Comino A; Vivenza D; Granetto C; Lo Nigro C; Ferrero M; Merlano MC;
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2015 Oct;96(1):167-82. doi: 10.1016/j.critrevonc.2015.06.001. Epub 2015 Jul
2015
AO Cuneo
AOU Città della Salute di Torino
Girolomoni G; Langendijk JA; Bensadoun RJ; Pinto C; Pergolizzi S; Denaro N; Licitra L; Merlano MC; Lombardo A; Airoldi M; Buglione M; Bossi P; Numico G; De Sanctis V; Bacigalupo A; Benasso M; Rampino M; Russi EG; Moretto F;
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2015 Nov;96(2):372-84. doi: 10.1016/j.critrevonc.2015.06.005. Epub 2015 Jun
2015
AO Cuneo
Murphy B; Langendijk JA; Merlano MC; Licitra L; Ripamonti C; Pavanato G; De Sanctis V; Bacigalupo A; Alterio D; Buglione M; Caspiani O; Orlandi E; Gava A; Numico G; Spadola Bissetti M; Merlotti A; Bossi P; Pizzorni N; Russi EG; Denaro N; Schindler A; Sanguineti G;
Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2015 Aug;95(2):191-213. doi: 10.1016/j.critrevonc.2015.03.003. Epub 2015 Mar
2015
AO Cuneo
AOU Città della Salute di Torino
Vermorken JB; Dellinger RP; Ranieri MV; Murphy B; Bernier J; Raber-Durlacher J; Cascio A; Pergolizzi S; Buglione M; Caspiani O; Denaro N; Moretto F; Licitra L; Merlano MC; Ghi MG; Merlotti A; Musso S; De Sanctis V; Bacigalupo A; Crippa F; Bossi P; Russi EG; Numico G; Mirabile A;
Retrospective evaluation of ADCC activity and cetuximab response in KRAS wild-type metastatic colorectal cancer patients (mCRC) in Annals of Oncology
2015
AO Cuneo
Ricci V; Vivenza D; Monteverde M; Strola G; Granetto C; Lo Nigro C; Merlano MC;
Biomarker analysis in recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC) patients (pts) treated with second-line afatinib versus methotrexate (MTX): LUX-Head & Neck 1 (LUX-H&N1) in Journal of Clinical Oncology
2015
AO Cuneo
Cohen EEW; Licitra LF; Fayette J; Gauler TC; Clement PM; Grau JJ; Del Campo JM; Mailliez A; Haddad RI; Vermorken JB; Tahara M; Guigay J; Geoffrois L; Merlano MC; Dupuis NF; Burtness B; Gibson N; Solca F; Ehrnrooth E; Machiels J-PH;
Non coding RNAs in head and neck squamous cell carcinoma (HNSCC): a clinical perspective. in Anticancer research / Anticancer Res. 2014 Dec;34(12):6887-96.
2014
AO Cuneo
Lo Nigro C; Russi EG; Merlano MC; Denaro N;
State-of-the-art and emerging treatment options in the management of head and neck cancer: news from 2013. in Oncology / Oncology. 2014;86(4):212-29. doi: 10.1159/000357712. Epub 2014 May 10.
2014
AO Cuneo
Denaro N; Russi EG; Adamo V; Merlano MC;
Dysphagia in Head and Neck Cancer Patients: Pretreatment Evaluation, Predictive Factors, and Assessment during Radio-Chemotherapy, Recommendations. in Clinical and experimental otorhinolaryngology / Clin Exp Otorhinolaryngol. 2013 Sep;6(3):117-26. doi: 10.3342/ceo.2013.6.3.117. Epub 2013 Sep 4.
2013
AO Cuneo
Denaro N; Merlano MC; Russi EG;
Swallowing dysfunction in head and neck cancer patients treated by radiotherapy: review and recommendations of the supportive task group of the Italian Association of Radiation Oncology. in Cancer treatment reviews / Cancer Treat Rev. 2012 Dec;38(8):1033-49. doi: 10.1016/j.ctrv.2012.04.002. Epub 2012 Apr 27.
2012
AO Cuneo
Bernier J; Bonomo P; Merlano MC; Zurlo V; Chiesa F; Sanguineti G; Paiar F; Ricardi U; Ruo Redda MG; De Sanctis V; Pergolizzi S; Franco P; Alterio D; Corvò R; Merlotti A; Russi EG;
The role of antiangiogenic agents in the treatment of head and neck cancer. in Oncology / Oncology. 2012;83(2):108-16. doi: 10.1159/000339542. Epub 2012 Jul 9.
2012
AO Cuneo
Denaro N; Russi EG; Colantonio I; Adamo V; Merlano MC;
The Role of p53 and MDM2 in Head and Neck Cancer. in ISRN otolaryngology / ISRN Otolaryngol. 2011 Dec 7;2011:931813. doi: 10.5402/2011/931813. Print 2011.
2011
AO Cuneo
Denaro N; Lo Nigro C; Natoli G; Russi EG; Adamo V; Merlano MC;